Nigel J Garrett
Overview
Explore the profile of Nigel J Garrett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1546
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Moosa Y, Tanko R, Ramsuran V, Singh R, Madzivhandila M, Yende-Zuma N, et al.
BMC Infect Dis
. 2018 Jan;
18(1):54.
PMID: 29370775
Background: The majority of people living with HIV require antiretroviral therapy (ART) for controlling viral replication, however there are rare HIV controllers who spontaneously and durably control HIV in the...
12.
Scheepers C, Chowdhury S, Wright W, Campbell C, Garrett N, Abdool Karim Q, et al.
AIDS
. 2017 Sep;
31(16):2199-2209.
PMID: 28926408
Background: The HIV-1 envelope is covered with glycans that provide structural integrity and protect conserved regions from host antibody responses. However, these glycans are often the target of broadly neutralizing...
13.
Anthony C, York T, Bekker V, Matten D, Selhorst P, Ferreria R, et al.
J Virol
. 2017 Jul;
91(18).
PMID: 28679760
V3-glycan-targeting broadly neutralizing antibodies (bNAbs) are a focus of HIV-1 vaccine development. Understanding the viral dynamics that stimulate the development of these antibodies can provide insights for immunogen design. We...
14.
Tanko R, Soares A, Muller T, Garrett N, Samsunder N, Abdool Karim Q, et al.
J Immunol
. 2017 Jan;
198(3):1220-1228.
PMID: 28039305
Human immunodeficiency virus infection induces a wide range of effects in B cells, including skewed memory cell differentiation, compromised B cell function, and hypergammaglobulinemia. However, data on the extent to...
15.
Sobieszczyk M, Werner L, Mlisana K, Naicker N, Feinstein A, Gray C, et al.
J Acquir Immune Defic Syndr
. 2016 Jul;
73(4):438-445.
PMID: 27391387
Background: Noncommunicable diseases are common among chronically infected patients with HIV in the developed world, but little is known about these conditions in African cohorts. We assessed the epidemiology of...
16.
Garrett N, McGrath N, Mindel A
Sex Transm Infect
. 2016 Apr;
93(1):4-5.
PMID: 27084840
No abstract available.
17.
Garrett N, Drain P, Werner L, Samsunder N, Abdool Karim S
J Acquir Immune Defic Syndr
. 2016 Mar;
72(2):e45-8.
PMID: 26959192
No abstract available.
18.
Mkhize N, Durgiah R, Ashley V, Archary D, Garrett N, Abdool Karim Q, et al.
AIDS
. 2016 Feb;
30(7):1005-14.
PMID: 26836790
Background: Broadly neutralizing antibodies (bNAbs) targeting conserved epitopes on the HIV envelope glycoprotein have been identified in blood from HIV-1 infected women. We investigated whether antibodies in the genital tract...
19.
Drain P, Garrett N
Lancet Glob Health
. 2015 Oct;
3(11):e663-4.
PMID: 26475005
No abstract available.
20.
Doria-Rose N, Bhiman J, Roark R, Schramm C, Gorman J, Chuang G, et al.
J Virol
. 2015 Oct;
90(1):76-91.
PMID: 26468542
Unlabelled: The epitopes defined by HIV-1 broadly neutralizing antibodies (bNAbs) are valuable templates for vaccine design, and studies of the immunological development of these antibodies are providing insights for vaccination...